BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6606214)

  • 21. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
    Sultan Y; Simeon J; Maisonneuve P; Caen JP
    Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factor VIII-like antigen in haemophilia A and in Willebrand's disease (author's transl)].
    Blatný J; Procházka J; Bártová A; Fischerová E; Slepicka L; Skodová M
    Cas Lek Cesk; 1975 Sep; 114(38):1174-6. PubMed ID: 1081010
    [No Abstract]   [Full Text] [Related]  

  • 23. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIDS surveillance in haemophilia.
    Daly HM; Palmer R; Scott GL; Lee G
    Br J Haematol; 1985 Feb; 59(2):383-90. PubMed ID: 3918559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against Australia-antigen in haemophilia.
    Nordenfelt E; Nilsson IM
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):151-5. PubMed ID: 5313698
    [No Abstract]   [Full Text] [Related]  

  • 26. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 27. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

  • 30. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 31. Reactivity to factor-VIII concentrates of lymphocytes from patients with haemophilia and von Willebrand's disease.
    Rossman RE; Brody JI
    Br J Haematol; 1974 Sep; 28(1):131-6. PubMed ID: 4606982
    [No Abstract]   [Full Text] [Related]  

  • 32. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two genetic variants of von Willebrand's disease.
    Holmberg L; Nilsson IM
    N Engl J Med; 1973 Mar; 288(12):595-8. PubMed ID: 4539979
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia A.
    Gralnick HR; Coller BS; Marchesi SL
    Thromb Res; 1975 Feb; 6(2):93-108. PubMed ID: 803726
    [No Abstract]   [Full Text] [Related]  

  • 35. A protocol for the dental management of von Willebrand's disease, haemophilia A and haemophilia B.
    Stubbs M; Lloyd J
    Aust Dent J; 2001 Mar; 46(1):37-40. PubMed ID: 11355239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C antibody and chronic liver disease in haemophilia.
    Makris M; Preston FE; Triger DR; Underwood JC; Choo QL; Kuo G; Houghton M
    Lancet; 1990 May; 335(8698):1117-9. PubMed ID: 1971863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations on choice of therapeutic products for the treatment of patients with haemophilia A, haemophilia B and von Willebrand's disease. UK Regional Haemophilia Centre Directors Committee.
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):205-14. PubMed ID: 1606293
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnosis of von Willebrand's disease].
    Baklaja R; Stojimirović E; Kezić J; Cuperlović K; Jovanović B; Cvetković V; Rasović N; Stajić M
    Bilt Hematol Transfuz; 1977; 5(3-4):41-61. PubMed ID: 307953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical staff conference: Hemophilia and von Willebrand's disease. Fourth annual Paul M. Aggeler memorial lecture.
    West J Med; 1974 Mar; 120(3):226-32. PubMed ID: 4544608
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.